Superoxide dismutase 3 polymorphism associated with reduced lung function in two large populations.
about
Pathogenic triad in COPD: oxidative stress, protease-antiprotease imbalance, and inflammationSuperoxide dismutase 3, extracellular (SOD3) variants and lung functionCOPD and stroke: are systemic inflammation and oxidative stress the missing links?Updates on the COPD gene listOxidative Stress in COPD: Sources, Markers, and Potential MechanismsExtracellular superoxide dismutase ameliorates skeletal muscle abnormalities, cachexia, and exercise intolerance in mice with congestive heart failure.Redox control of asthma: molecular mechanisms and therapeutic opportunities.Pharmacogenetics of chronic obstructive pulmonary disease: challenges and opportunities.Genetic variation in antioxidant enzymes, cigarette smoking, and longitudinal change in lung functionNovel aspects of oxidative stress in cardiovascular diseases.Extracellular superoxide dismutase and risk of COPD.Polymorphisms in the superoxide dismutase-3 gene are associated with emphysema in COPD.Extracellular superoxide dismutase protects against pulmonary emphysema by attenuating oxidative fragmentation of ECM.Correlation of apical fluid-regulating channel proteins with lung function in human COPD lungsThe role of genetic polymorphisms in antioxidant enzymes and potential antioxidant therapies in neonatal lung diseaseSecreted phosphoprotein 1 is a determinant of lung function development in mice.The link between chronic periodontitis and COPD: a common role for the neutrophil?A common polymorphism in extracellular superoxide dismutase affects cardiopulmonary disease risk by altering protein distribution.Genetic and epigenetic inactivation of extracellular superoxide dismutase promotes an invasive phenotype in human lung cancer by disrupting ECM homeostasis.Regulation of lung oxidative damage by endogenous superoxide dismutase in sepsis.Histone deacetylation contributes to low extracellular superoxide dismutase expression in human idiopathic pulmonary arterial hypertension.Markers of early disease and prognosis in COPD.Endogenous enzymes (NOX and ECSOD) regulate smoke-induced oxidative stress.Recent advances in pre-clinical mouse models of COPD.Meta-analyses on suspected chronic obstructive pulmonary disease genes: a summary of 20 years' research.Current perspectives of oxidative stress and its measurement in chronic obstructive pulmonary disease.Current concepts on oxidative/carbonyl stress, inflammation and epigenetics in pathogenesis of chronic obstructive pulmonary disease.Update in chronic obstructive pulmonary disease: role of antioxidant and metabolizing gene polymorphisms.Pharmacological antioxidant strategies as therapeutic interventions for COPD.Heterogeneity of chronic obstructive pulmonary disease: from phenotype to genotype.Muscle-derived extracellular superoxide dismutase inhibits endothelial activation and protects against multiple organ dysfunction syndrome in mice.Plasma 25-hydroxyvitamin D, lung function and risk of chronic obstructive pulmonary disease.On the Origin of Superoxide Dismutase: An Evolutionary Perspective of Superoxide-Mediated Redox Signaling.Mechanisms and Consequences of Oxidative Stress in Lung Disease: Therapeutic Implications for an Aging Populace.Sialylation of extracellular superoxide dismutase (EC-SOD) enhances furin-mediated cleavage and secretion.Extracellular matrix in lung development, homeostasis and disease.N-Glycosylation is essential for the secretion of extracellular superoxide dismutase.RNAseq analysis of bronchial epithelial cells to identify COPD-associated genes and SNPs.
P2860
Q24615052-A4C57D58-1674-4112-BACC-6A4F2A21AC65Q24657554-9020CA98-4A26-4D93-B31B-AC37E01D32EBQ26746530-15E38D73-D816-4494-9686-E88DA5EC3065Q26824935-870175D9-A526-4158-8225-4DD39BA11C9CQ29247910-66FCDA84-6E17-4919-A699-3B9F7FAF775DQ30405450-E62AA226-B3D5-4A90-809B-0AC33C7244A4Q33668491-0E6F7224-F7AC-4E06-8CE7-9065F6333B2EQ33706037-44EE29C2-73C1-45F5-A11E-C005EDD4C6D8Q33765854-6051D8BC-064F-425A-B73B-CB1FFCDE50CBQ33815017-95FE4DEF-0355-4080-B770-8F55E58CE637Q33821221-3B211637-B86C-4AF5-A7AC-09039AB9A7ECQ34074050-3ABDF979-E692-43A3-B351-34A4982D0661Q34100348-2014B49B-411D-49B0-AA93-C8EBE4526EEFQ34361842-609E8E6C-0835-445C-97FE-75641F34A126Q34370825-37DBD659-09EE-489B-8298-F0772F767DD0Q34471236-2C1B3492-3329-4DE7-A0D6-98AD37184838Q34478144-B8667851-0333-43A6-BDEB-68E9B528E5CDQ34735375-CEBDC3EE-19E5-44BA-86AB-AC5273489EE4Q35683231-C1FF764D-86A3-4BFC-98E0-0C5B49A66BCAQ35883629-9AC53DDF-16DF-4C09-9804-6010E970EDBCQ37139542-21DF36D5-6EBC-4473-9705-7EEF789BD6F1Q37168317-76DA83C6-FBC9-4BCE-84DC-8EBD7F973610Q37192215-B09A72AD-E77D-4AE8-8A09-5B870897F1A7Q37426720-2EA74B4C-218F-4BAA-BD32-B232D679E0E5Q37553688-7B3F7C74-5764-4323-9E46-95C2DB68600AQ37776727-46D26711-1354-46A8-A3FC-FE9481E24FF3Q37836078-12B4805B-126E-4CBD-A021-858AA9DE1C1BQ37896652-3596EDFE-0B8B-4904-965F-7F7B935D7484Q37958591-E9520D43-E60F-47AA-A675-1380D5F42CECQ38162802-F065B474-9D6B-4278-A563-18619CC75A4AQ41990697-C0893672-E3BB-4C3E-8F52-EAB00E21D1FDQ44385923-2A0F851C-34A8-4A86-91F4-89141F177727Q46272318-9FF2519E-69A0-4E29-927C-62B70FC2771AQ47652510-D679909C-AC01-4D3A-877A-4DF492406D78Q50065172-705326B5-29E3-4330-840A-F0F3F194B14FQ50420061-DFBA25A2-5015-4A3C-A28B-278F4721832BQ51547283-1DBA9CE3-6F19-4F43-B48C-ECB9B62C2599Q52728819-19A0BBB1-6D65-47CD-9725-CDB8AB700D79
P2860
Superoxide dismutase 3 polymorphism associated with reduced lung function in two large populations.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Superoxide dismutase 3 polymor ...... tion in two large populations.
@en
type
label
Superoxide dismutase 3 polymor ...... tion in two large populations.
@en
prefLabel
Superoxide dismutase 3 polymor ...... tion in two large populations.
@en
P2093
P2860
P1476
Superoxide dismutase 3 polymor ...... tion in two large populations.
@en
P2093
James D Crapo
Klaus Juul
Russell P Bowler
Samuel Levy
P2860
P304
P356
10.1164/RCCM.200804-549OC
P407
P577
2008-08-14T00:00:00Z